A systematic review on anti-Alzheimer's disease activity of prescription Kangen-karyu

Paudel P, Park CH, Jung HA, Yokozawa T, Choi JS

Drug Discov Ther. 2020; 14(2):61-66.

DOI: 10.5582/ddt.2020.03013

Summary Full Text (PDF)

Treatment of SARS-CoV-2: How far have we reached?

Ahsan W, Javed S, Bratty MA, Alhazmi HA, Najmi A

Drug Discov Ther. 2020; 14(2):67-72.

DOI: 10.5582/ddt.2020.03008

Summary Full Text (PDF)

Rapid review for the anti-coronavirus effect of remdesivir

Li ZY, Wang XJ, Cao DL, Sun RL, Li C, Li GW

Drug Discov Ther. 2020; 14(2):73-76.

DOI: 10.5582/ddt.2020.01015

Summary Full Text (PDF)

Effects of the combined administration of risedronate and menatetrenone on bone loss induced by tacrolimus in rats

Kanda J, Furukawa M, Izumo N, Shimakura T, Yamamoto N, Takahashi HE, Wakabayashi H

Drug Discov Ther. 2020; 14(2):77-83.

DOI: 10.5582/ddt.2020.03012

Summary Full Text (PDF)

Therapeutic effect of Chinese prescription Kangen-karyu in patients with diabetic nephropathy

Park CH, Hiratani K, Natazuka T, Yokozawa T

Drug Discov Ther. 2020; 14(2):84-88.

DOI: 10.5582/ddt.2020.01013

Summary Full Text (PDF)

Change of serum cytokine profiles by propranolol treatment in patients with infantile hemangioma

Tani S, Kunimoto K, Inaba Y, Mikita N, Kaminaka C, Kanazawa N, Yamamoto Y, Kakimoto N, Suenaga T, Takeuchi T, Suzuki H, Jinnin M

Drug Discov Ther. 2020; 14(2):89-92.

DOI: 10.5582/ddt.2020.03014

Summary Full Text (PDF)

Brain abscess in patients with chronic kidney disease: A casebased approach to management in resource-limited settings

Gupta N, Kumar R, Banerjee S, Singh G, Malla S, Ray Y, Ramteke P, George N, Kodan P, Aggarwal A, Kumar P, Jorwal P, Soneja M, Biswas A

Drug Discov Ther. 2020; 14(2):93-97.

DOI: 10.5582/ddt.2019.01062

Summary Full Text (PDF)

Visual improvement in a patient with paracentral acute middle maculopathy treated with prostaglandin E1

Steigerwalt RD, Nebbioso M

Drug Discov Ther. 2020; 14(2):98-99.

DOI: 10.5582/ddt.2020.03002

Summary Full Text (PDF)

Treat 2019 novel coronavirus (COVID-19) with IL-6 inhibitor: Are we already that far?

Zhang YY, Zhong YY, Pan L, Dong J

Drug Discov Ther. 2020; 14(2):100-102.

DOI: 10.5582/ddt.2020.03006

Summary Full Text (PDF)

Ultra-low price of generic agents in China may weaken patients' drug recognition and compliance

Lu SH, Cai J, Xu F

Drug Discov Ther. 2020; 14(2):103-104.

DOI: 10.5582/ddt.2020.01011

Summary Full Text (PDF)

Facts and reflections on COVID-19 and anti-hypertensives drugs

Marin GH (on behalf of GAPURMED-Argentine Group for the Rational Use of Medicines)

Drug Discov Ther. 2020; 14(2):105-106.

DOI: 10.5582/ddt.2020.01017

Summary Full Text (PDF)

Is GSK3β a molecular target of chloroquine treatment against COVID-19?

Embi MN, Ganesan N, Sidek HM

Drug Discov Ther. 2020; 14(2):107-108.

DOI: 10.5582/ddt.2020.03010

Summary Full Text (PDF)